CIAS
DGX icon

CBIZ Investment Advisory Services’s Quest Diagnostics DGX Stock Holding History

CBIZ Investment Advisory Services’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.08K Hold
31
– – ﹤0.01% 203
2026
Q1 		$6.08K Sell
31
-13
-30% -$2.53K ﹤0.01% 203
2025
Q4 		$7.63K Buy
44
+13
+42% +$2.37K ﹤0.01% 433
2025
Q3 		$5.91K Buy
31
+30
+3,000% +$5.32K ﹤0.01% 425
2025
Q2 		$180 Buy
+1
New +$174 ﹤0.01% 696

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

CBIZ Investment Advisory Services's DGX Position: Q2 2026 in Review

CBIZ Investment Advisory Services held its Quest Diagnostics (DGX) position steady in Q2 2026 at 31 shares worth $6.08K. The position accounts for ﹤0.01% of the portfolio, ranked #203.

CBIZ Investment Advisory Services first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.63K in Q4 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • CBIZ Investment Advisory Services held 31 shares of Quest Diagnostics worth $6.08K as of Q2 2026.
  • CBIZ Investment Advisory Services left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of CBIZ Investment Advisory Services's portfolio in Q2 2026, its #203 holding.
  • CBIZ Investment Advisory Services first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • CBIZ Investment Advisory Services's Quest Diagnostics position peaked at $7.63K in Q4 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q2 2026, filed 13 Aug 2026.